Wall Street Analysts Release These New Price Targets

Edwards Lifesciences (NYSE:EW): Canaccord Genuity reiterated its rating of Buy for this company and changed its price target from $93 to $103.

Tempur-Pedic (NYSE:TPX): Stifel Nicolaus reiterated its rating of Buy for this company and changed its price target from $89 to $30. Longbow reiterated its rating of Buy for this company and changed its price target from $77 to $39.